
TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 20
IS  - S1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185X.13178
DO  - doi:10.1111/1756-185X.13178
SP  - 17
EP  - 131
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 30
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.30.10.1086
DO  - doi:10.1592/phco.30.10.1086
SP  - 1086
EP  - 1086
PY  - 2010
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2008: oral presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 95
IS  - S3
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6224
DO  - doi:10.1002/bjs.6224
SP  - 1
EP  - 86
PY  - 2008
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at Bournemouth International Centre, Bournemouth, UK (14th ? 16th May 2008), under the presidency of Professor Brian J Rowlands. To view all abstracts of oral presentations from this meeting, please click the pdf link on this page. Copyright ? 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodynam.
VL  - 35
IS  - S4
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.23074
DO  - doi:10.1002/nau.23074
SP  - S1
EP  - S471
PY  - 2016
ER  - 

TY  - JOUR
TI  - Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19–22 June 2018
JO  - The Journal of Pathology
JA  - J. Pathol
VL  - 246
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.5165
DO  - doi:10.1002/path.5165
SP  - S1
EP  - S46
PY  - 2018
ER  - 

TY  - JOUR
TI  - ACVIM Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 19
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2005.tb02714.x
DO  - doi:10.1111/j.1939-1676.2005.tb02714.x
SP  - 386
EP  - 488
PY  - 2005
ER  - 

TY  - JOUR
TI  - TUESDAY 30 NOVEMBER 2010
JO  - Early Intervention in Psychiatry
VL  - 4
IS  - s1
SN  - 1751-7885
UR  - https://doi.org/10.1111/j.1751-7893.2010.00215.x
DO  - doi:10.1111/j.1751-7893.2010.00215.x
SP  - 16
EP  - 29
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol
VL  - 54
IS  - S1
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.24373
DO  - doi:10.1002/ppul.24373
SP  - S81
EP  - S148
PY  - 2019
ER  - 

TY  - JOUR
AU  - Revel-Vilk, Shoshana
AU  - Szer, Jeff
AU  - Mehta, Atul
AU  - Zimran, Ari
TI  - How we manage Gaucher Disease in the era of choices
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 182
IS  - 4
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15402
DO  - doi:10.1111/bjh.15402
SP  - 467
EP  - 480
KW  - Gaucher disease
KW  - pathophysiology
KW  - inflammation
PY  - 2018
AB  - Summary Treatment of Gaucher Disease (GD) is now beset with the abundance of therapeutic options for an individual patient, making the choice of therapy complex for both expert and non-expert clinicians. The pathogenesis of all disease manifestations is a gene mutation-driven deficiency of glucocerebrosidase, but the clinical expression and response of each of the clinical manifestations to different therapies can be difficult to predict. Enzyme replacement therapy has been available since 1991 and is well-established, with known efficacy and minimal toxicity. Of interest, the three available enzymes are distinct molecules and were registered as new products, not biosimilars. Oral substrate reduction therapy has undergone a revitalisation with a newly approved agent in this class for which some efficacy and toxicity questions have been raised. Herein we present our approach to the management of GD in the era of choices, including a new algorithm for how to manage a newly diagnosed patient.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_2.x
DO  - doi:10.1111/j.1538-7836.2009.03473_2.x
SP  - 317
EP  - 1168
PY  - 2009
ER  - 

AU  - Hoffman, Richard
AU  - Gerber, Mariette
C7  - pp. 173-186
TI  - Epidemiological Methods
SN  - 9781444330021
UR  - https://doi.org/10.1002/9781118785027.ch8
DO  - doi:10.1002/9781118785027.ch8
SP  - 173-186
PY  - 2009
ER  - 

TY  - JOUR
TI  - Short Communications
JO  - European Journal of Neurology
VL  - 16
IS  - s3
SN  - 9781444330021
UR  - https://doi.org/10.1111/j.1468-1331.2009.02820.x
DO  - doi:10.1111/j.1468-1331.2009.02820.x
SP  - 16
EP  - 54
PY  - 2009
ER  - 

TY  - JOUR
TI  - RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 33
IS  - 2
SN  - 9781444330021
UR  - https://doi.org/10.1111/jvim.15372
DO  - doi:10.1111/jvim.15372
SP  - 1015
EP  - 1101
PY  - 2019
ER  - 

TY  - JOUR
AU  - Kauwell, Gail P. A.
TI  - Emerging Concepts in Nutrigenomics: A Preview of What Is to Come
JO  - Nutrition in Clinical Practice
JA  - Nutr Clin Pract
VL  - 20
IS  - 1
SN  - 9781444330021
UR  - https://doi.org/10.1177/011542650502000175
DO  - doi:10.1177/011542650502000175
SP  - 75
EP  - 87
PY  - 2005
AB  - This article provides an overview of the fundamental principles of genetics and emerging concepts related to the ways in which nutrients and bioactive food components may interact with the genome and subsequently affect human health. This exciting area of research is likely to have far-reaching implications for the assessment and treatment of critically and chronically ill individuals that will affect nutrition standards of care and practice. A brief overview of some of the ethical, legal, and social implications of genomic research and genome-based health care and a list of genetics resources also are provided.
ER  - 

TY  - JOUR
TI  - e-Posters
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 101
IS  - s2
SN  - 9781444330021
UR  - https://doi.org/10.1002/bjs.9475
DO  - doi:10.1002/bjs.9475
SP  - 7
EP  - 14
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 26
IS  - S2
SN  - 9781444330021
UR  - https://doi.org/10.1002/mds.23764
DO  - doi:10.1002/mds.23764
SP  - S1
EP  - S385
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Internal Medicine Journal
JA  - Intern Med J
VL  - 45
IS  - S2
SN  - 9781444330021
UR  - https://doi.org/10.1111/imj.12752
DO  - doi:10.1111/imj.12752
SP  - 1
EP  - 46
PY  - 2015
ER  - 

TY  - JOUR
TI  - Indexes to Volume 56: Subject index
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 56
IS  - 6
SN  - 9781444330021
UR  - https://doi.org/10.1002/ana.11256
DO  - doi:10.1002/ana.11256
SP  - 927
EP  - 982
PY  - 2004
ER  - 

TY  - JOUR
AU  - Kenow, Kevin P.
AU  - Grasman, Keith A.
AU  - Hines, Randy K.
AU  - Meyer, Michael W.
AU  - Gendron-Fitzpatrick, Annette
AU  - Spalding, Marilyn G.
AU  - Gray, Brian R.
TI  - Effects of methylmercury exposure on the immune function of juvenile common loons (Gavia immer)
JO  - Environmental Toxicology and Chemistry
JA  - Environmental Toxicology and Chemistry
VL  - 26
IS  - 7
SN  - 9781444330021
UR  - https://doi.org/10.1897/06-442R.1
DO  - doi:10.1897/06-442R.1
SP  - 1460
EP  - 1469
KW  - Common loon
KW  - Immune function
KW  - Gavia immer
KW  - Methylmercury
KW  - Mercury
PY  - 2007
AB  - Abstract We conducted a dose-response laboratory study to quantify the level of exposure to dietary Hg, delivered as methyl-mercury chloride (CH3HgCl), that is associated with suppressed immune function in captive-reared common loon (Gavia immer) chicks. We used the phytohemagglutinin (PHA) skin test to assess T-lymphocyte function and the sheep red blood cell (SRBC) hemagglutination test to measure antibody-mediated immunity. The PHA stimulation index among chicks receiving dietary Hg treatment did not differ significantly from those of chicks on the control diet (p = 0.15). Total antibody (immunoglobulin [Ig] M [primary antibody] + IgG [secondary response]) production to the SRBC antigen in chicks treated with dietary methylmercury (MeHg), however, was suppressed (p = 0.04) relative to chicks on control diets. Analysis indicated suppression of total Ig production (p = 0.025 with comparisonwise α level = 0.017) between control and 0.4 ?g Hg/g wet food intake treatment groups. Furthermore, the control group exhibited a higher degree of variability in antibody response compared to the Hg groups, suggesting that in addition to reducing the mean response, Hg treatment reduced the normal variation attributable to other biological factors. We observed bursal lymphoid depletion in chicks receiving the 1.2 ?g Hg/g treatment (p = 0.017) and a marginally significant effect (p = 0.025) in chicks receiving the 0.4 ?g Hg/g diet. These findings suggest that common loon chick immune systems may be compromised at an ecologically relevant dietary exposure concentration (0.4 ?g Hg/g wet wt food intake). We also found that chicks hatched from eggs collected from low-pH lakes exhibited higher levels of lymphoid depletion in bursa tissue relative to chicks hatched from eggs collected from neutral-pH lakes.
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - Journal of Diabetes Investigation
VL  - 3
IS  - s1
SN  - 9781444330021
UR  - https://doi.org/10.1111/jdi.12012
DO  - doi:10.1111/jdi.12012
SP  - 79
EP  - 146
PY  - 2012
ER  - 
